Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Non-steroidal Anti-inflammatory Drugs (NSAID) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Non-steroidal Anti-inflammatory Drugs (NSAID) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-steroidal Anti-inflammatory Drugs (NSAID) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Human and Animals are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Non-steroidal Anti-inflammatory Drugs (NSAID) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-steroidal Anti-inflammatory Drugs (NSAID) key manufacturers include Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial and Merck Animal Health, etc. Bayer, Ecotrin, Generic are top 3 players and held % sales share in total in 2022.
Non-steroidal Anti-inflammatory Drugs (NSAID) can be divided into Salicylates, Propionic acid derivatives, Acetic acid derivatives and Enolic acid (Oxicam) derivatives, etc. Salicylates is the mainstream product in the market, accounting for % sales share globally in 2022.
Non-steroidal Anti-inflammatory Drugs (NSAID) is widely used in various fields, such as Human, Animals and Others,, etc. Human provides greatest supports to the Non-steroidal Anti-inflammatory Drugs (NSAID) industry development. In 2022, global % sales of Non-steroidal Anti-inflammatory Drugs (NSAID) went into Human filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-steroidal Anti-inflammatory Drugs (NSAID) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
Segment by Type
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Human
Animals
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Non-steroidal Anti-inflammatory Drugs (NSAID) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Non-steroidal Anti-inflammatory Drugs (NSAID), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-steroidal Anti-inflammatory Drugs (NSAID) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-steroidal Anti-inflammatory Drugs (NSAID) introduction, etc. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Non-steroidal Anti-inflammatory Drugs (NSAID) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Non-steroidal Anti-inflammatory Drugs (NSAID) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-steroidal Anti-inflammatory Drugs (NSAID) key manufacturers include Bayer, Ecotrin, Generic, St. Joseph, Elanco, Zoetis, Boehringer Ingelheim, Merial and Merck Animal Health, etc. Bayer, Ecotrin, Generic are top 3 players and held % sales share in total in 2022.
Non-steroidal Anti-inflammatory Drugs (NSAID) can be divided into Salicylates, Propionic acid derivatives, Acetic acid derivatives and Enolic acid (Oxicam) derivatives, etc. Salicylates is the mainstream product in the market, accounting for % sales share globally in 2022.
Non-steroidal Anti-inflammatory Drugs (NSAID) is widely used in various fields, such as Human, Animals and Others,, etc. Human provides greatest supports to the Non-steroidal Anti-inflammatory Drugs (NSAID) industry development. In 2022, global % sales of Non-steroidal Anti-inflammatory Drugs (NSAID) went into Human filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-steroidal Anti-inflammatory Drugs (NSAID) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer
Ecotrin
Generic
St. Joseph
Elanco
Zoetis
Boehringer Ingelheim
Merial
Merck Animal Health
Segment by Type
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
Segment by Application
Human
Animals
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Non-steroidal Anti-inflammatory Drugs (NSAID) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Non-steroidal Anti-inflammatory Drugs (NSAID), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-steroidal Anti-inflammatory Drugs (NSAID) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-steroidal Anti-inflammatory Drugs (NSAID) introduction, etc. Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Non-steroidal Anti-inflammatory Drugs (NSAID) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices